|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2007-5-21
|
|
pubmed:abstractText |
The name scleroderma is given to a spectrum of diseases which differ clinically and bear different prognostic risks. The origins of the various forms of the disease are unclear. A toxic influence has been suggested, particularly for the progressive systemic scleroderma. However, the imputability of the suspected chemicals often remains unsettled.
|
|
pubmed:language |
fre
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Mar
|
|
pubmed:issn |
0370-629X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
62
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
170-4
|
|
pubmed:meshHeading |
pubmed-meshheading:17511386-Autoantibodies,
pubmed-meshheading:17511386-Biological Markers,
pubmed-meshheading:17511386-Diagnosis, Differential,
pubmed-meshheading:17511386-Humans,
pubmed-meshheading:17511386-Hydrocarbons, Aromatic,
pubmed-meshheading:17511386-Prognosis,
pubmed-meshheading:17511386-Scleroderma, Diffuse,
pubmed-meshheading:17511386-Scleroderma, Localized,
pubmed-meshheading:17511386-Scleroderma, Systemic,
pubmed-meshheading:17511386-Silicon Dioxide
|
|
pubmed:year |
2007
|
|
pubmed:articleTitle |
[How I explore...the revisited toxic path of scleroderma].
|
|
pubmed:affiliation |
CHU du Sart Tilman, Service de Dermatopathologie, Liège, Belgique. pascale.quatresooz@chu.ulg.ac.be
|
|
pubmed:publicationType |
Journal Article,
English Abstract,
Review
|
